Wilmington, Delaware, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Immunohematology Market by Product (Analyzers and Systems and Reagents), Application (Blood-related Diseases, HIV and Others), End User (Hospitals, Diagnostic Laboratories and Others): Global Opportunity Analysis and Industry Forecast, 2024-2033". According to the report, the global immunohematology market was valued at $1.9 billion in 2023, and is estimated to reach $3.0 billion by 2033, growing at a CAGR of 4.6% from 2024 to 2033.
Request Sample of the Report on Immunohematology Market Forecast 2033 - https://www.alliedmarketresearch.com/request-sample/2126
Prime determinants of growth
Rising prevalence of blood disorders and chronic diseases, rise in geriatric population, increasing blood donations are the major factors that drive the growth of the immunohematology market growth. However, lack of awareness about the importance of immunohematology testing restricts the market growth. Moreover, technological advancements in immunohematology products offer remunerative opportunities for the expansion of the global immunohematology market.
Report coverage & details
| Report Coverage | Details |
| Forecast Period | 2024–2033 |
| Base Year | 2023 |
| Market Size in 2023 | $1.9 billion |
| Market Size in 2033 | $3.0 billion |
| CAGR | 4.6% |
| No. of Pages in Report | 233 |
| Segments Covered | Product, Application, End User and Region. |
| Drivers | Rising prevalence of blood disorders and chronic diseases |
| Rise in geriatric population | |
| Increasing blood donations | |
| Opportunity | Technological advancements |
| Restraint | Lack of awareness about the importance of immunohematology testing |
Want to Explore More, Connect to our Analyst - https://www.alliedmarketresearch.com/connect-to-analyst/2126
Segment Highlights
The immunohematology segment dominated the market share in 2023
By product, the immunohematology segment dominated the market share in 2023 owing to increase in prevalence of chronic diseases and the growing number of surgical procedures requiring blood transfusions. As healthcare systems worldwide advance, there is an increased focus on ensuring safe and efficient blood management practices. Immunohematology reagents play a crucial role in blood typing, antibody screening, and crossmatching, which are essential for preventing transfusion-related complications.
The blood related diseases segment segment dominated the market share in 2023
By application, blood related diseases segment the dominated the market share in 2023. This is attributed to rise in prevalence of conditions such as anemia, leukemia, lymphoma, and various hemoglobinopathies require precise diagnosis and careful management, which heavily depend on accurate blood typing, antibody screening, and crossmatching. Immunohematology tests are crucial for identifying specific blood group antigens and antibodies, ensuring that patients receive compatible and safe blood transfusions.
The hospitals segment dominated the market share in 2023
By end user, the hospitals segment dominated the market share in 2023. This is attributed to well-established laboratories equipped with advanced diagnostic tools and automated systems capable of handling large volumes of blood tests efficiently. These facilities employ skilled medical professionals who are trained in the latest immunohematology techniques, ensuring high accuracy and reliability in blood typing, antibody screening, and crossmatching procedures. The prevalence of chronic diseases such as cancer, cardiovascular disorders, and renal diseases, which often necessitate repeated blood transfusions, further increases the demand for immunohematology services within hospital settings.
For Purchase Related Queries/Inquiry - https://www.alliedmarketresearch.com/purchase-enquiry/2126
Regional Outlook
North America to maintain its dominance by 2033
North America holds a significant share of the global immunohematology market, primarily driven by the advanced healthcare infrastructure, high healthcare expenditure, and widespread adoption of cutting-edge technologies. The rise in prevalence of blood-related disorders such as anemia, leukemia, and lymphoma are high, necessitating robust hematology diagnostics and treatments further contributes towards the market growth.
Key Players
- Bio-Rad Laboratories, Inc
- Werfen
- Grifols, S.A.
- Danaher Corporation
- Siemens
- Thermo Fisher Scientific Inc.
- Abbott Laboratories
- Merck KGaA
- F. Hoffmann-La Roche Ltd
- Cardinal Health
The report provides a detailed analysis of these key players in the global immunohematology market. These players have adopted different strategies such as product launch, product approval, and others to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario.
Get Customized Reports with your Requirements - https://www.alliedmarketresearch.com/request-for-customization/2126
Recent Developments in Immunohematology Market Worldwide
- In October 2022, Bio-Rad Laboratories, Inc. and the South African National Blood Service (SANBS) , a leading provider of blood transfusion services in eight out of nine provinces in South Africa, announced that they had substantially completed the rollout of Bio-Rad’s IH-500 immunohematology systems across the SANBS network of transfusion medicine laboratories, as part of an exclusive agreement finalized in early 2022.
- In March 2022, Quotient Limited a commercial-stage diagnostics company announced that it has received Conformité Européenne (CE) Mark for its MosaiQ Extended Immunohematology (IH) Microarray.
Trending Reports in Healthcare Industry:
Patient Monitoring Devices Market - Global Opportunity Analysis and Industry Forecast, 2023-2032
Needle-free Injection Systems Market - Global Opportunity Analysis and Industry Forecast, 2023-2032
Molecular Diagnostics Market - Global Opportunity Analysis and Industry Forecast, 2023-2032
Coronary Stents Market - Global Opportunity Analysis and Industry Forecast, 2023-2032
AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) Offered by Allied Market Research:
AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.
Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access
About Allied Market Research:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact
David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Toll Free: +1-800-792-5285
Int’l: +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
Web: https://www.alliedmarketresearch.com
Follow Us on: LinkedIn Twitter
